Portfolio Finder

Threedy commercializes its instant3D hub platform – a visual computing platform for industrial customers to translate the ever growing web of 3D, business and process data into highly responsive and interactive 3D applications.

Till

Exit

Development and distribution of direct digital printing machines for packaging.

Exit since Nov. 2011. Acquisition: KRONES

tiramizoo.com is an online marketplace for delivery services leveraging existing courier and delivery services infrastructure in urban areas. Customers find, book and pay the ideal courier or delivery service online. Local onlineshops can offer fast and green delivery through new checkout options.

Exit since July 2013.

Development and marketing of systems for high speed and reliable data transfer over wide area networks. Tixel’s TIXstream-technology offers the world’s highest data transfer rates.

TM3

Exit

TM3 has developed an enterprise resource planning system (ERP-System) for small and medium-sized companies with a focus on real-time booking and inventory management. Moreover, solutions for claims management and demand forecasting based on artificial intelligence are provided.

Exit since March 2011. Purchaser: S-Refit AG

TolerogenixX GmbH has developed a patented and clinically tested cell therapy technique for individualised immunosuppression in transplant patients. The technique enables the targeted disabling of undesired reactions caused by the immune system’s defences.

Tomorrow Things is an intelligent automation platform that creates digital twins of technical assets. Complex, error-prone, and cost-intense manual integrations are being substituted by technology. Blueprints connect assets with the click of a mouse, so customers can collect and stream data for enhanced decision-making, improved operational efficiency, and optimized sustainability. The blueprint technology supports plug-and-produce and drives interoperability within the entire ecosystem. It allows for seamless integration of third-party applications on top of digitalized assets.

Toolify Robotics GmbH, founded in March 2020 in Ulm by Dr. Dennis Stampfer, Dr. Matthias Lutz, and Dr. Alex Lotz, consists of a team of six full-time employees with extensive software expertise and over 15 years of experience in automation and service robotics. Toolify's mission is to make the complex world of robotics easily accessible and enable companies to take advantage of modern robots to drive efficiency and growth.

AI

Tracekey offers a smart and lean track and trace solution as a Software-as-a-Service (SaaS) which enables our customers to make each product unique, distinctive and unequivocally verifiable in order to create and document an unbroken traceability over the entire product life cycle. As the first European supplier of a cloud based serialization solution tracekey focus on the pharmaceutical industry.

The circular bioeconomy startup traceless materials has developed a holistically sustainable alternative for plastics and bioplastics that is fully compostable in nature, contributing to solve the global plastic pollution.

As an agency for performance advertising TrackScale offers individual online and offline campaign solutions that can be measured and optimized by the unique tracking technology in real-time.

Berlin-based startup traide was founded in 2021 by Leonie Althaus, Philipp Friebertshäuser and Hendrik Niemann. The team leverages the latest cloud and AI technologies to help companies meet their customs obligations and automate their customs processes. The company's SaaS solution handles product master data as well as purchasing and ordering processes and is suitable for companies of all sizes and industries.

TRAIT is based in Berlin and was founded by Raphael Jung and Matthias Ettrich. Since 2021, the company operated under the name "Twaiv" and focused on AI-generated, adaptive training plans, before relaunching under the name TRAIT in July 2024. Since its inception, the company has experienced rapid growth with an annual increase in downloads of 178%. Trait has raised around 1 million € in seed funding from HTGF, the angel club better ventures and other investors.

The Trans-Duodenal Barrier developed by TDC is a patented endoscopic transduodenal bypass implant for combined diabetes/obesity therapy that atraumatically prevents nutrient absorption in the duodenum and delays gastric emptying.

The present prototype has successfully completed initial animal studies (ZIM-funded). Following successful CE certification, commercialization as a class IIb product is expected to start in 2027.

The Trans-Duodenal Barrier is a globally unique product for the pronounced growth market of obesity, DMT2 and NASH (approx. 800 million patients worldwide) and already has a sales potential in the billions at 0.1% penetration.

The uniqueness of the Trans-Duodenal Barrier is based in particular on the patented method of fixation and therefore also allows much broader use than previous methods for combining restrictive and malabsorptive principles of action.

Die Einzigartigkeit der Trans-Duodenal Barrier fußt insbesondere auf der patentierten Art der Fixierung und erlaubt daher auch wesentlich breitere Verwendung als bisherige Verfahren zur Kombination restriktiver und malabsorptiver Wirkprinzipien

The FinTech company troy is changing the traditional debt collection industry with methods from marketing and CRM. The aim of the start-up with the locations in Lippstadt (NRW) and Hamburg is to maintain the relationship between the company and the customer in addition to the realisation of the receivables. The founders of troy, Philip Rürup and Till Völzke, rely on multichannel communication as well as individualized and data-driven communication in combination with decades of debt collection expertise. The mission: troy becoming the most customer-friendly debt collection company in Europe.
About half of consumers are in default of payment due to forgetfulness or short-term bottlenecks. Despite that, traditional debt collection treats these customers as if they have not paid intentionally. The process is impersonal, bureaucratic and unpleasant. It is obvious that as a result, companies usually lose their customers. troy changes this and continues to treat the customer as a customer. Tried and tested methods of multichannel CRM, targeting approaches and machine learning drive the new approach. troy addresses each customer via the most promising mix of communication channels and with individually adjusted messages. High transparency, multiple payment methods and friendly communication add to the “troy way”. This allows for high recovery rates of both receivables and customer relationships.

Tubulis generates uniquely matched protein-drug conjugates by combining proprietary novel technologies with disease-specific biology. Our goal is to expand the therapeutic potential of antibody drug conjugates (ADCs) ushering in a new era and delivering better outcomes for patients. Employing the company’s proprietary ADC development approach, Tubulis will advance a variety of conjugates, unlimited by indication

Twenty-One Semiconductors GmbH was founded in 2019 as a spin-off of the Institute of Semiconductor Optics and Functional Interfaces (IHFG) at the University of Stuttgart. The company produces and markets a completely new type of laser crystals that can be used to efficiently generate laser radiation in the visible spectral range.
The underlying MEXL technology enables laser manufacturers to realize a new generation of laser sources for biomedical applications to obtain more detailed information when analysing cell and tissue samples.

uberMetrics Technologies is a technology provider for (social) media monitoring. The tool uberMetrics DELTA gathers data from public communication, extracts the relevant content for the client and makes it accessible in a SaaS-Tool for its analysis.

Umlaut.bio GmbH develops small molecules that are intended to be used as first-in-class therapeutics against a variety of diseases. The focus is on the “umlauts” of the genetic code – chemically modified RNA nucleotides. These play a crucial role in gene regulation and are of great importance, for example, in cancer cells. There, modified tRNAs protect protein-coding mRNAs from degradation and thus promote tumor growth. Therapeutic modalities that specifically address this mechanism could be able to selectively prevent the growth of cancer cells. This approach promises a disruptive novel form of cancer therapy that could offer a new, gentler treatment option for many patients.

Uniki’s Edge Computing solution increases productivity between teams, customers and partners and securely connects devices and company locations.
It provides modern Cloud applications for all areas of business on a maintenance-free, scalable on premise platform with an unprecedented level of security – from data exchange to collaboration, project management, CRM, ERP and many more. As the world’s first private Cloud-App-Platform it combines the advantages of Software-as-a-Service in the Cloud with 100% data sovereignty and familiar integration into the local IT infrastructure (e.g. network shares, Outlook, industry specific software).

Urban Ground is a curated marketplace. Private tenants get are offered a fully digitized renting experience and landlords get a guaranteed rental income.

Key to Userlane’s technology are interactive step-by-step guides, which can be implemented on top of every existing web-based software or e-commerce website. These interactive guides lead every user through all processes and show them real-time where to click next within the software – just like GPS navigation systems in cars advice drivers turn-by-turn how to optimally reach the destination. This way complex software can be easily used, without previous knowledge, making extensive software training obsolete.

VACIS is the leading tissue engineering company for body-own blood vessels.
The VACIS technology uses a synthetic rod which induces the formation of a new fully functional blood vessel providing novel therapeutic options for vascular surgery. Prosthetic vascular graft failure is a frequent complication in vascular surgery with substantial morbidity and health care costs. VACIS provides patients autologous graft vessels, with sustained patency and fewer complications requiring less corrective interventions.
Vascular grafts are needed in many areas of medicine. VACIS initially focuses on vascular access in patients undergoing hemodialysis. Other indications will follow after clinical validation of the technology in hemodialysis. Such other indications include peripheral arterial occlusive disease.
VACIS provides an advantage over other therapeutic options in the hemodialysis access market. Current solutions have a low patency: many arteriovascular fistulas fail to mature or no adequate vein is available; the foreign material in synthetic grafts lead to infection, stenosis, thrombosis etc. and the synthetic material does not heal after cannulation.

Vanatec offers with OpenAccess a so-called object-relational mapping tool, which reduces the programming effort regarding data access to relational databases under .NET by 90%, by creating an application and database-independent mapping between object model and data model.

Successful exit since March 2006. Purchaser: Telerik GmbH

Venly was founded in 2018 as Arkane Network and is a blockchain tech provider focussing on 3 main products:

- Venly Wallets: with our wallet services we help blockchain projects onboard their users by providing blockchain agnostic wallets.
- Venly Market and APIs: the Venly Market is a peer-to-peer NFT marketplace. With our Market APIs projects are able to build an NFT marketplace backed by our technology.
- Venly NFT Tools: the right tools to build fast and securely. From minting tools to a complete asset management system for Unity or webshop plugins to scale fast.

In April 2021, Venly closed a €1.55M seed round led by HTGF. Venly recently added Tioga Capital to its list of investors with an additional €500k funding, bringing the total of +2M€ in funding to continue its growth.

Veodin develops software for management consultants. The flagship product “SlideProof” is a PowerPoint Add-In for proofing presentations. It's the fastest way to improve visual consistency of a deck while increasing productivity & efficiency.

Verovaccines is a biopharmaceutical company developing combination vaccines for animal health using a new proprietary technology. These vaccines offer several solutions for medical and industry needs in animal health: new vaccines to reduce antibiotic use, simple vaccine combinations and heat-stable vaccines for widespread use in emerging and developing countries. The technology can be used for many pathogens and is highly scalable. The company has built a portfolio of six vaccine programs, three of which achieved proof of concept in the target animal.

Vertama specialises in accelerating manual workflows by designing and implementing accessible, digital micro-processes in existing system environments. With its in-house developed platform for innovative web applications and a comprehensive toolkit of different modules, Vertama quickly implements flexible and scalable solutions.

Theft of photovoltaik- (PV) modules leads to yearly losses adding up into the millions. The Viamon anti module is an intelligent system, integrated in the connection box of PV-modules, which permanently monitors the solar field and sets off an alarm, in case of theft.

viboo makes buildings more energy efficient through its Predictive Control as a Service platform. Rooted in extensive research at Empa and ETH Zurich, the company empowers smart thermostats with predictive algorithms, reducing energy usage by 20-40% in both light-commercial and residential buildings. With partnerships across the value chain, including Danfoss, ABB, Netatmo and Bouygues, viboo is ready to make buildings more energy efficient and sustainable.